COYA position history
The shares of Coya Therapeutics (COYA) that DME Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 1,274,026 shares, $13M, 0.58% of portfolio
- 2024 Q2: 1,274,026 shares, $7.7M, 0.38% of portfolio
- 2024 Q3: 1,274,026 shares, $8.2M, 0.34% of portfolio
- 2024 Q4: 1,646,440 shares, $9.4M, 0.49% of portfolio, Add +29.2%
- 2025 Q1: 1,646,440 shares, $11M, 0.54% of portfolio
- 2025 Q2: 1,646,440 shares, $9.5M, 0.41% of portfolio
- 2025 Q3: 1,646,440 shares, $9.4M, 0.37% of portfolio
- 2025 Q4: 2,025,940 shares, $12M, 0.41% of portfolio, Add +23.0%
- 2026 Q1: 2,335,540 shares, $9.2M, 0.29% of portfolio, Add +15.3%
- 2026 Q2: 2,335,540 shares, $14M, 0.35% of portfolio
- 2026 Q3: 2,335,540 shares, $12M, 0.33% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|